Author

C. D. House

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Abdelmaksoud· 1 shared B. S. Harrington· 1 shared B. Tran· 1 shared C. M. Annunziata· 1 shared C. Wang· 1 shared D. Butcher· 1 shared E. Edmondson· 1 shared F. Elloumi· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Abdelmaksoud

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

UGDH promotes tumor-initiating cells and a fibroinflammatory tumor microenvironment in ovarian cancer.

B. S. Harrington, R. D. Kamdar, S. Korrapati, M. W. Caminear, F. Ning, L. F. Hernandez, D. Butcher, E. Edmondson, N. Traficante, M. Gough, R. Rogers, R. Lourie, J. Shetty, B. Tran, F. Elloumi, , C. M. Annunziata

This study identifies UGDH as a driver of tumor-initiating cells and fibroinflammatory microenvironment in ovarian cancer, with subtype-specific effects on prognosis and tumor growth.

Journal of Experimental & Clinical Cancer Research · Oct 19, 2023Peer-reviewedCancer Biology

Characterization of SOX2, OCT4 and NANOG in ovarian cancer tumor-initiating cells

M. Robinson, S. F. Gilbert, J. A. Waters, O. Lujano-Olazaba, J. Lara, R. Holmberg, L. J. Alexander, S. E. Green, G. Burkeen, O. Patrus, C. Wang, C. D. House

This study evaluates SOX2, OCT4, and NANOG expression in ovarian cancer cell lines under 2-D and 3-D culture conditions, finding SOX2 is more strongly associated with tumor-initiating cells and chemotherapy resistance.

bioRxiv · Sep 8, 2020Cancer Biology